Biosurveillance requires the gathering and interpretation of large amounts of data in order to achieve detection and early warning of health threats, whether natural or intentional, and allows for situational awareness of disease activity. The flexibility of the open-architecture xMAP® chemistry enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. No other solution addresses the needs of applications requiring both high density and high throughput at the same time. The Luminex technology allows for advanced diagnostics and environmental detection capabilities against a full spectrum of disease and threat agents.
For more information, please contact:
Matthew J. Lesho, Ph.D.
Director, Government Business Development